UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Chikungunya infection in travelers

Emerging infectious diseases, 2006-10, Vol.12 (10), p.1565-1567

2006

Volltextzugriff (PDF)

Features of Mpox infection: The analysis of the data submitted to the ID-IRI network

New microbes and new infections, 2023-06, Vol.53, p.101154-101154, Article 101154

2023

Volltextzugriff (PDF)

Detection of Aspergillus Galactomannan Antigenemia To Determine Biological and Clinical Implications of Beta-Lactam Treatments

Journal of Clinical Microbiology, 2005-10, Vol.43 (10), p.5214-5220

2005

Volltextzugriff (PDF)

Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.594-600

2003

Volltextzugriff (PDF)

Hypersensitivity Syndrome Associated with Efavirenz Therapy

Clinical infectious diseases, 2000-01, Vol.30 (1), p.227-228

2000

Volltextzugriff (PDF)

Les facteurs potentiels de décrochage professionnel chez les 45–55 ans

Archives des maladies professionnelles et de l'environnement, 2020-10, Vol.81 (5), p.546-546

2020

Volltextzugriff (PDF)

Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers

PloS one, 2008-12, Vol.3 (12), p.e4087-e4087

2008

Volltextzugriff (PDF)

HHV-6 variant A meningoencephalitis after allogeneic hematopoietic stem cell transplantation diagnosed by quantitative real-time polymerase chain reaction

Transplantation, 2005-08, Vol.80 (4), p.539

2005

Volltextzugriff (PDF)

Discontinuation of Secondary Prophylaxis against Disseminated Mycobacterium avium Complex Infection and Toxoplasmic Encephalitis

Clinical infectious diseases, 2002-03, Vol.34 (5), p.662-667

2002

Volltextzugriff (PDF)

Stevens-Johnson Syndrome Associated with Abacavir Therapy

Clinical infectious diseases, 2002-10, Vol.35 (7), p.902-902

2002

Volltextzugriff (PDF)

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

Journal of medical virology, 2004-09, Vol.74 (1), p.16-20

2004

Volltextzugriff (PDF)

The European Commission's Task Force on Bioterrorism

Emerging infectious diseases, 2003-10, Vol.9 (10), p.1330-1332

2003

Volltextzugriff (PDF)

The Level of Human Immunodeficiency Virus (HIV) Type 1 RNA in Cerebrospinal Fluid As a Marker of HIV Encephalitis

Clinical infectious diseases, 1998-05, Vol.26 (5), p.1072-1073

1998

Volltextzugriff (PDF)

Toxoplasma gondii-Associated Guillain-Barré Syndrome in an Immunocompetent Patient

Journal of Clinical Microbiology, 1998-12, Vol.36 (12), p.3724-3725

1998

Volltextzugriff (PDF)

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Journal of Clinical Microbiology, 1999-09, Vol.37 (9), p.2910-2912

1999

Volltextzugriff (PDF)

Severe acute disseminated toxoplasmosis

The Lancet (British edition), 2004-08, Vol.364 (9434), p.579-579

2004

Volltextzugriff (PDF)

Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases

The Lancet infectious diseases, 2009-01, Vol.9 (1), p.45-56

2009

Volltextzugriff (PDF)

Low T Cell Responses to Human Herpesvirus 8 in Patients with AIDS-Related and Classic Kaposi Sarcoma

The Journal of infectious diseases, 2006-10, Vol.194 (8), p.1078-1088

2006

Volltextzugriff (PDF)

Brucellose par bioterrorisme

La Presse médicale (1983), 2004, Vol.33 (2), p.119-122

2004

Volltextzugriff (PDF)

Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans

The Journal of clinical investigation, 2010-05, Vol.120 (5), p.1636-1644

2010

Volltextzugriff (PDF)

Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia

Euro surveillance : bulletin européen sur les maladies transmissibles, 2004-12, Vol.9 (12), p.E9-28

2004

Volltextzugriff (PDF)

Control of vaccinia virus skin lesions by long-term-maintained IFN-[gamma]+TNF-[alpha]+ effector/memory CD4+ lymphocytes in humans

The Journal of clinical investigation, 2010-05, Vol.120 (5), p.1636

2010

Volltextzugriff (PDF)

Control of vaccinia virus skin lesions by long-term-maintained [IFN-γ.sup.+][TNF-α.sup.+] effector/memory [CD4.sup.+] lymphocytes in humans

The Journal of clinical investigation, 2010-05, Vol.120 (5), p.1636

2010

Volltextzugriff (PDF)

Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses

Euro surveillance : bulletin européen sur les maladies transmissibles, 2004-12, Vol.9 (12), p.E11-30

2004

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(83)
Science & Technology
(79)
Life Sciences & Biomedicine
(72)
Male
(39)
Adult
(33)
Infectious Diseases
(33)
Female
(31)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Sciences Biologiques Et Medicales
(24)
Sciences Medicales
(24)
General & Internal Medicine
(23)
Medicine, General & Internal
(23)
Middle Aged
(22)
Bioterrorism - Prevention & Control
(19)
Communicable Disease Control - Organization & Administration
(17)
Europe
(17)
Immunology
(16)
Life Sciences
(16)
Microbiology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chikungunya infection in travelers

Features of Mpox infection: The analysis of the data submitted to the ID-IRI network

Detection of Aspergillus Galactomannan Antigenemia To Determine Biological and Clinical Implications of Beta-Lactam Treatments

Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients with AIDS Treated with Highly Active Antiretroviral Therapy: An International Observational Study

Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Hypersensitivity Syndrome Associated with Efavirenz Therapy

Les facteurs potentiels de décrochage professionnel chez les 45–55 ans

Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers

HHV-6 variant A meningoencephalitis after allogeneic hematopoietic stem cell transplantation diagnosed by quantitative real-time polymerase chain reaction

Discontinuation of Secondary Prophylaxis against Disseminated Mycobacterium avium Complex Infection and Toxoplasmic Encephalitis

Stevens-Johnson Syndrome Associated with Abacavir Therapy

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

The European Commission's Task Force on Bioterrorism

The Level of Human Immunodeficiency Virus (HIV) Type 1 RNA in Cerebrospinal Fluid As a Marker of HIV Encephalitis

Toxoplasma gondii-Associated Guillain-Barré Syndrome in an Immunocompetent Patient

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Severe acute disseminated toxoplasmosis

Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases

Low T Cell Responses to Human Herpesvirus 8 in Patients with AIDS-Related and Classic Kaposi Sarcoma

Brucellose par bioterrorisme

Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans

Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia

Control of vaccinia virus skin lesions by long-term-maintained IFN-[gamma]+TNF-[alpha]+ effector/memory CD4+ lymphocytes in humans

Control of vaccinia virus skin lesions by long-term-maintained [IFN-γ.sup.+][TNF-α.sup.+] effector/memory [CD4.sup.+] lymphocytes in humans

Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses

Suchergebnisse filtern